Coexpression cluster:C726: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:29, 17 September 2013
Full id: C726_chronic_CD4_Hodgkin_CD8_thymus_CD19_blood
Phase1 CAGE Peaks
Hg19::chr10:6622629..6622638,+ | p4@uc001ijl.2 |
Hg19::chr10:6622667..6622678,+ | p5@uc001ijl.2 |
Hg19::chr11:118211212..118211232,- | p@chr11:118211212..118211232 - |
Hg19::chr11:6423982..6423997,- | p9@APBB1 |
Hg19::chr15:22448832..22448885,- | p1@AJ004954 |
Hg19::chr1:117307142..117307156,+ | p3@CD2 |
Hg19::chr1:117307157..117307178,+ | p2@CD2 |
Hg19::chr1:117311220..117311234,+ | p@chr1:117311220..117311234 + |
Hg19::chr2:99388276..99388311,- | p3@ENST00000448595 |
Hg19::chr2:99388349..99388378,- | p1@ENST00000448595 |
Hg19::chr9:35649814..35649823,- | p@chr9:35649814..35649823 - |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0030887 | positive regulation of myeloid dendritic cell activation | 0.00239899918896269 |
GO:0050760 | negative regulation of thymidylate synthase biosynthetic process | 0.00239899918896269 |
GO:0050758 | regulation of thymidylate synthase biosynthetic process | 0.00239899918896269 |
GO:0050757 | thymidylate synthase biosynthetic process | 0.00239899918896269 |
GO:0051665 | lipid raft localization | 0.00239899918896269 |
GO:0031580 | lipid raft distribution | 0.00239899918896269 |
GO:0001766 | lipid raft polarization | 0.00239899918896269 |
GO:0030885 | regulation of myeloid dendritic cell activation | 0.00239899918896269 |
GO:0001773 | myeloid dendritic cell activation | 0.00383828571022355 |
GO:0031579 | lipid raft organization and biogenesis | 0.00383828571022355 |
GO:0045749 | negative regulation of S phase of mitotic cell cycle | 0.00610609398962248 |
GO:0045580 | regulation of T cell differentiation | 0.0073369270873641 |
GO:0001540 | beta-amyloid binding | 0.0073369270873641 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 0.0073369270873641 |
GO:0045930 | negative regulation of progression through mitotic cell cycle | 0.0073369270873641 |
GO:0007009 | plasma membrane organization and biogenesis | 0.0073369270873641 |
GO:0051668 | localization within membrane | 0.0073369270873641 |
GO:0033261 | regulation of progression through S phase | 0.00784942111105822 |
GO:0045619 | regulation of lymphocyte differentiation | 0.00784942111105822 |
GO:0000084 | S phase of mitotic cell cycle | 0.00784942111105822 |
GO:0030101 | natural killer cell activation | 0.00784942111105822 |
GO:0030426 | growth cone | 0.00784942111105822 |
GO:0030427 | site of polarized growth | 0.00792514425191407 |
GO:0051320 | S phase | 0.00839414904394305 |
GO:0048468 | cell development | 0.00870786176931244 |
GO:0002274 | myeloid leukocyte activation | 0.0099614067426714 |
GO:0007346 | regulation of progression through mitotic cell cycle | 0.0113680113202635 |
GO:0048731 | system development | 0.0126841943224681 |
GO:0030027 | lamellipodium | 0.0126841943224681 |
GO:0030217 | T cell differentiation | 0.0126841943224681 |
GO:0017148 | negative regulation of translation | 0.0126841943224681 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.0134858298228399 |
GO:0048869 | cellular developmental process | 0.0136017999257637 |
GO:0030154 | cell differentiation | 0.0136017999257637 |
GO:0009890 | negative regulation of biosynthetic process | 0.0139726535835333 |
GO:0030308 | negative regulation of cell growth | 0.0139942492563816 |
GO:0045792 | negative regulation of cell size | 0.0139942492563816 |
GO:0050863 | regulation of T cell activation | 0.0145514290056884 |
GO:0048856 | anatomical structure development | 0.0145514290056884 |
GO:0045926 | negative regulation of growth | 0.0146211869705408 |
GO:0030098 | lymphocyte differentiation | 0.0149654475969592 |
GO:0031252 | leading edge | 0.0164333313353733 |
GO:0051249 | regulation of lymphocyte activation | 0.01694189346195 |
GO:0007275 | multicellular organismal development | 0.0169587749440453 |
GO:0050865 | regulation of cell activation | 0.017039964487941 |
GO:0051329 | interphase of mitotic cell cycle | 0.0177100711960359 |
GO:0002521 | leukocyte differentiation | 0.0179691892931388 |
GO:0051325 | interphase | 0.0179691892931388 |
GO:0042110 | T cell activation | 0.0191648754036795 |
GO:0007050 | cell cycle arrest | 0.0193556682424319 |
GO:0051248 | negative regulation of protein metabolic process | 0.019538929159613 |
GO:0007409 | axonogenesis | 0.0210026976150678 |
GO:0048667 | neuron morphogenesis during differentiation | 0.0212874009302865 |
GO:0048812 | neurite morphogenesis | 0.0212874009302865 |
GO:0000904 | cellular morphogenesis during differentiation | 0.0219434337308529 |
GO:0031175 | neurite development | 0.0230879213432029 |
GO:0048666 | neuron development | 0.0254244349158173 |
GO:0046649 | lymphocyte activation | 0.0254244349158173 |
GO:0016043 | cellular component organization and biogenesis | 0.0254244349158173 |
GO:0030097 | hemopoiesis | 0.0254244349158173 |
GO:0001558 | regulation of cell growth | 0.0254244349158173 |
GO:0032502 | developmental process | 0.0255122121187149 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.0262752118608913 |
GO:0045321 | leukocyte activation | 0.0262752118608913 |
GO:0002520 | immune system development | 0.0262752118608913 |
GO:0006417 | regulation of translation | 0.0262752118608913 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0262752118608913 |
GO:0016049 | cell growth | 0.0262752118608913 |
GO:0040008 | regulation of growth | 0.0262752118608913 |
GO:0032990 | cell part morphogenesis | 0.0262752118608913 |
GO:0048858 | cell projection morphogenesis | 0.0262752118608913 |
GO:0030030 | cell projection organization and biogenesis | 0.0262752118608913 |
GO:0008361 | regulation of cell size | 0.0262752118608913 |
GO:0001775 | cell activation | 0.0262752118608913 |
GO:0030182 | neuron differentiation | 0.0262752118608913 |
GO:0006917 | induction of apoptosis | 0.0262752118608913 |
GO:0012502 | induction of programmed cell death | 0.0262752118608913 |
GO:0032501 | multicellular organismal process | 0.0262752118608913 |
GO:0009889 | regulation of biosynthetic process | 0.0262752118608913 |
GO:0045786 | negative regulation of progression through cell cycle | 0.0269001568217935 |
GO:0048699 | generation of neurons | 0.0285682467560399 |
GO:0043065 | positive regulation of apoptosis | 0.0297161269138546 |
GO:0043068 | positive regulation of programmed cell death | 0.0297161269138546 |
GO:0022008 | neurogenesis | 0.0298158318010825 |
GO:0051239 | regulation of multicellular organismal process | 0.0311450839206244 |
GO:0016044 | membrane organization and biogenesis | 0.0315575748587551 |
GO:0042995 | cell projection | 0.0343654970695894 |
GO:0000278 | mitotic cell cycle | 0.0353792794685426 |
GO:0016337 | cell-cell adhesion | 0.0372236214630119 |
GO:0000074 | regulation of progression through cell cycle | 0.0374431864112437 |
GO:0051726 | regulation of cell cycle | 0.0376578140057725 |
GO:0022403 | cell cycle phase | 0.0382803873763502 |
GO:0031324 | negative regulation of cellular metabolic process | 0.0390933314854237 |
GO:0007165 | signal transduction | 0.0397200677172096 |
GO:0051246 | regulation of protein metabolic process | 0.0423629181842233 |
GO:0008134 | transcription factor binding | 0.0428569954657122 |
GO:0009892 | negative regulation of metabolic process | 0.0428569954657122 |
GO:0007154 | cell communication | 0.0445454702098529 |
GO:0000902 | cell morphogenesis | 0.0454903912728169 |
GO:0032989 | cellular structure morphogenesis | 0.0454903912728169 |
GO:0050794 | regulation of cellular process | 0.0454903912728169 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hemopoietic organ | 8.89e-15 | 7 |
immune organ | 8.89e-15 | 7 |
blood | 2.34e-14 | 15 |
haemolymphatic fluid | 2.34e-14 | 15 |
organism substance | 2.34e-14 | 15 |
thymus | 1.08e-12 | 4 |
hemolymphoid system gland | 1.08e-12 | 4 |
thymic region | 1.08e-12 | 4 |
pharyngeal gland | 1.08e-12 | 4 |
thymus primordium | 1.08e-12 | 4 |
pharyngeal epithelium | 1.84e-08 | 6 |
chordate pharynx | 2.26e-07 | 10 |
pharyngeal region of foregut | 2.26e-07 | 10 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.0768054 |
MA0004.1 | 0.349539 |
MA0006.1 | 0.210781 |
MA0007.1 | 0.885261 |
MA0009.1 | 0.79061 |
MA0014.1 | 0.559573 |
MA0017.1 | 1.26613 |
MA0019.1 | 0.486183 |
MA0024.1 | 0.688373 |
MA0025.1 | 0.921763 |
MA0027.1 | 2.39404 |
MA0028.1 | 0.637069 |
MA0029.1 | 0.707146 |
MA0030.1 | 0.696006 |
MA0031.1 | 1.53137 |
MA0038.1 | 0.443833 |
MA0040.1 | 0.712837 |
MA0041.1 | 0.366339 |
MA0042.1 | 0.337481 |
MA0043.1 | 0.790919 |
MA0046.1 | 0.779945 |
MA0048.1 | 0.729247 |
MA0050.1 | 0.897608 |
MA0051.1 | 0.439895 |
MA0052.1 | 0.716602 |
MA0055.1 | 0.279754 |
MA0056.1 | 0 |
MA0057.1 | 0.176435 |
MA0058.1 | 0.265212 |
MA0059.1 | 0.2641 |
MA0060.1 | 0.119532 |
MA0061.1 | 1.12119 |
MA0063.1 | 0 |
MA0066.1 | 0.444231 |
MA0067.1 | 1.1037 |
MA0068.1 | 0.0758327 |
MA0069.1 | 0.776171 |
MA0070.1 | 0.765217 |
MA0071.1 | 0.40788 |
MA0072.1 | 0.760818 |
MA0073.1 | 0.00428338 |
MA0074.1 | 0.439193 |
MA0076.1 | 0.278993 |
MA0077.1 | 0.753278 |
MA0078.1 | 0.533387 |
MA0081.1 | 0.26424 |
MA0083.1 | 0.79797 |
MA0084.1 | 1.28962 |
MA0087.1 | 0.758426 |
MA0088.1 | 0.467716 |
MA0089.1 | 0 |
MA0090.1 | 0.291627 |
MA0091.1 | 0.351901 |
MA0092.1 | 0.318032 |
MA0093.1 | 0.213288 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.456802 |
MA0101.1 | 0.617985 |
MA0103.1 | 0.203171 |
MA0105.1 | 0.15707 |
MA0106.1 | 0.482519 |
MA0107.1 | 0.475157 |
MA0108.2 | 0.630531 |
MA0109.1 | 0 |
MA0111.1 | 0.303543 |
MA0113.1 | 0.498009 |
MA0114.1 | 1.45594 |
MA0115.1 | 1.02805 |
MA0116.1 | 0.159642 |
MA0117.1 | 0.827487 |
MA0119.1 | 0.250314 |
MA0122.1 | 0.852927 |
MA0124.1 | 0.98702 |
MA0125.1 | 0.904129 |
MA0130.1 | 0 |
MA0131.1 | 0.550695 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.820382 |
MA0136.1 | 0.450422 |
MA0139.1 | 1.57257 |
MA0140.1 | 1.04551 |
MA0141.1 | 0.2626 |
MA0142.1 | 1.46715 |
MA0143.1 | 1.24556 |
MA0144.1 | 0.142196 |
MA0145.1 | 0.115359 |
MA0146.1 | 0.951488 |
MA0147.1 | 0.162359 |
MA0148.1 | 0.372124 |
MA0149.1 | 0.396509 |
MA0062.2 | 0.659456 |
MA0035.2 | 1.04409 |
MA0039.2 | 0.00136845 |
MA0138.2 | 0.534556 |
MA0002.2 | 0.358551 |
MA0137.2 | 0.229531 |
MA0104.2 | 0.118985 |
MA0047.2 | 1.18756 |
MA0112.2 | 0.260758 |
MA0065.2 | 0.839576 |
MA0150.1 | 0.286461 |
MA0151.1 | 0 |
MA0152.1 | 0.411494 |
MA0153.1 | 0.887528 |
MA0154.1 | 0.153348 |
MA0155.1 | 0.74825 |
MA0156.1 | 0.654264 |
MA0157.1 | 1.41182 |
MA0158.1 | 0 |
MA0159.1 | 0.162854 |
MA0160.1 | 0.386031 |
MA0161.1 | 0 |
MA0162.1 | 0.00470038 |
MA0163.1 | 0.387319 |
MA0164.1 | 0.509774 |
MA0080.2 | 0.611699 |
MA0018.2 | 0.483823 |
MA0099.2 | 0.411824 |
MA0079.2 | 0.00715613 |
MA0102.2 | 1.32663 |
MA0258.1 | 0.420151 |
MA0259.1 | 0.168926 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
EBF1#1879 | 5 | 4.04839402116773 | 0.00459238325242163 | 0.0217024395701205 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.